Ingevity Q3 net income rises to $51.1 million; sales fall 8% on Road Markings sale
Ingevity reported third-quarter 2026 results, with net sales down 8% to $305.1 million, mainly because of the April 15, 2026 sale of the Road Markings product line. Net income from continuing operations rose to $51.1 million, or $1.46 per diluted share, from $40.8 million, or $1.10, a year earlier. The company narrowed its full-year adjusted EBITDA outlook to $385 million to $395 million while keeping the midpoint of the prior range, and said the timing of an Advanced Polymer Technologies sale agreement may extend into early 2027.
Key points
- Net sales of $305.1 million fell 8%; excluding Road Markings, sales rose 2%.
- Net income from continuing operations was $51.1 million, or $1.46 per diluted share, versus $1.10 a year earlier.
- Adjusted EBITDA was $108.0 million, down $2.4 million; full-year adjusted EBITDA outlook narrowed to $385 million to $395 million.
- Management said the timing of an Advanced Polymer Technologies sale agreement may extend into early 2027.
The filing
Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.